Greenway Medical goes public

Luke Gale | | Health Exec | Policy & Regulations
Health IT vendor Greenway Medical went public Feb. 2, offering an initial public offering will make available approximately 6.7 million shares of common stock at $10 per share.

The shares began trading on the New York Stock Exchange Feb. 2 under the symbol “GWAY.”

J.P. Morgan and Morgan Stanley are acting as active book-runners for the Carrollton, Ga.-based company.

Luke Gale

Related Content

Over 1,000 hospitals earn $700M opioid crisis judgement
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.